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Identifying communities with lower rates of mammogra-
phy screening is a critical step to providing targeted
screening programs; however, population-based data nec-
essary for identifying these geographic areas are limited.
This study presents methods to identify geographic dis-
parities in the early detection of breast cancer.
Methods
Data for all women residing in Dane County, Wisconsin,
at the time of their breast cancer diagnosis from 1981
through 2000 (N = 4769) were obtained from the Wisconsin
Cancer Reporting System (Wisconsin’s tumor registry) by
ZIP code of residence. Hierarchical logistic regression mod-
els for disease mapping were used to identify geographic
differences in the early detection of breast cancer.
Results
The percentage of breast cancer cases diagnosed in situ
(excluding lobular carcinoma in situ) increased from 1.3%
in 1981 to 11.9% in 2000. This increase, reflecting increas-
ing mammography use, occurred sooner in Dane County
than in Wisconsin as a whole. From 1981 through 1985,
the proportion of breast cancer diagnosed in situ in Dane
county was universally low (2%–3%). From 1986 through
1990, urban and suburban ZIP codes had significantly
higher rates (10%) compared with rural ZIP codes (5%).
From 1991 through 1995, mammography screening had
increased in rural ZIP codes (7% of breast cancer diag-
nosed in situ). From 1996 through 2000, mammography
use was fairly homogeneous across the entire county
(13%–14% of breast cancer diagnosed in situ).
Conclusion
The percentage of breast cancer cases diagnosed in situ
increased in the state and in all areas of Dane County from
1981 through 2000. Visual display of the geographic differ-
ences in the early detection of breast cancer demonstrates
the diffusion of mammography use across the county over
the 20-year period.
Introduction
Geographic differences in health status and use of health
services have been reported in the United States and inter-
nationally (1), including stage of breast cancer incidence and
mammography screening practices (2). Early diagnosis of
breast cancer through mammography screening improves
breast cancer treatment options and may reduce mortality
(3,4), yet many women in the United States are not routine-
ly screened according to recommended guidelines (5).
Needs assessment to account for noncompliance with
breast cancer screening recommendations has focused on
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personal factors related to participation, including the bar-
riers women perceive (6), the role of physicians (7), and the
role of services such as mobile vans (8) and insurance cov-
erage (9). Evaluations of the effectiveness of interventions
directed at patients, communities, and special populations
have also provided important information about mammog-
raphy use (10). However, little attention has been paid to
geographic location, except to focus on inner-city and rural
disparities in mammography use (11,12).
The purpose of this study was to identify geographic dis-
parities in the early detection of breast cancer using cancer
registry data. This information can be used to identify
areas where increased mammography screening is needed
and to understand the diffusion of innovation in an urban
or a rural setting.
Cancer registry data were used for these analyses.
Validity of the use of these data rests on the correlation
between the percentage of breast cancer diagnosed in situ
and mammography screening rates; breast cancer in situ
(BCIS) (excluding lobular carcinoma in situ [13-15]) is the
earliest stage of localized breast cancer and is diagnosed
almost exclusively by mammography (16). In the 1970s,
before widespread use of mammography, BCIS represent-
ed less than 2% of breast cancer cases in the United States
(15). A nationwide community-based breast cancer screen-
ing program showed that among populations of women
screened regularly, the stage distribution of diagnosed
cases was skewed to earlier stages, with BCIS accounting
for more than 35% (17). Trends in the relative frequency of
BCIS are closely correlated with trends in mammography
use (reflected in data from surveys of mammography
providers in Wisconsin) and with trends in self-reported
mammography use (reflected in data from the Behavioral
Risk Factor Surveillance System) (18-20).
In Wisconsin, either a physician can refer a patient for
screening or a woman can self-refer. More than 60% of
the mammography imaging facilities in the state accept
self-referrals (21). Since 1989, Wisconsin state law has
mandated health insurance coverage for women aged 45
to 65 years, and Medicare covers mammography screen-
ing for eligible women (22). In Wisconsin, the
Department of Health and Family Services provides a
toll-free number through which women can contact more
than 400 service providers (22). Finally, several programs
such as the Wisconsin Well Woman Program, which is
funded by the Centers for Disease Control and




All female breast cancer cases diagnosed from 1981
through 2000 were identified by the Wisconsin Cancer
Reporting System (WCRS). The WCRS was established in
1976 as mandated by Wisconsin state statute to collect
cancer incidence data on Wisconsin residents. In compli-
ance with state law, hospitals and physicians are required
to report cancer cases to the WCRS (within 6 months of
initial diagnosis for hospitals and within 3 months for
physicians, through their clinics). Variables obtained from
the WCRS included histology (International Classification
of Diseases for Oncology, 2nd Edition [ICD-02] codes),
stage (0 = in situ, 1 = localized, 2–5 = regional, 7 = distant,
and 9 = unstaged), year of diagnosis, county of residence
at time of diagnosis, and number of incident cases in 5-
year age groups by ZIP code for all breast cancer cases
among women. ZIP codes and county of residences, self-
reported by the women with diagnosed breast cancer, are
provided to the WCRS. Only ZIP codes verified for Dane
County by the U.S. Postal Service were included in the
data set (n = 37). The ZIP code was the smallest area unit
available for WCRS incidence data.
Study location and characteristics
Dane County is located in south central Wisconsin. The
population of the county in 1990 was 367,085, with 20% of
the population living in rural areas (23); approximately
190,000 people lived in Madison, the second largest city in
Wisconsin and home to the University of Wisconsin. The
37 unique ZIP codes in Dane County incorporate 60 cities,
villages, and towns (Figure 1).
Data analysis
We determined the percentage of breast cancer cases
diagnosed as BCIS in Wisconsin and Dane County over
time and by ZIP codes for Dane County. For ZIP codes
that encompassed areas beyond the borders of Dane
County, only women who reported their county of resi-
dence as Dane were included in the analysis. The per-
centage of BCIS by ZIP code was mapped using 1996 ZIP
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code boundary files. For 17 breast cancer cases in which
the women’s ZIP codes no longer existed, each ZIP code
was reassigned to the ZIP code in the same location.
We used analytic methods to estimate rates of early
breast cancer detection by ZIP code. Because of small num-
bers of BCIS cases in each ZIP code, a well-characterized
statistical method was used to stabilize the prediction of
rates by borrowing information from neighboring ZIP
codes (24). This is done by using Bayesian hierarchical
logistic regression models to estimate ZIP-code–specific
effects on percentage of breast cancer cases diagnosed in
situ (excluding lobular carcinoma in situ). ZIP-code–specif-
ic effects (log odds ratios) were modeled as a Gaussian con-
ditional autoregression (CAR) (25). Using the CAR model,
one assumes that the log odds ratio for one ZIP code is
influenced by the average log odds ratio for its neighbors.
The conditional standard deviation of the CAR model, the
free parameter which controls the smoothness of the map,
was given a uniform prior (24).
For each time period, two CAR models were fitted. The
first model included age group as the only covariate. Age
group effects were modeled using an exchangeable normal
prior. The standard deviation of this distribution was given
a uniform prior. The second model included additional ZIP-
code–level covariates. Potential covariates were urban or
rural status, education, median household income, marital
status, employment status, and commuting time from the
Summary Tape File 3 of the 1990 U.S. Census of
Population and Housing (23). Census data from 1990 were
used because 1990 is the midpoint of the years included in
these analyses (1981–2000). Urban or rural status was
defined as percentage of women living in each of the four
census classifications: urban inside urbanized area, urban
outside of urbanized area, rural farm, and rural nonfarm
for each ZIP code. Education was defined as percentage of
women in each ZIP code aged 25 years and older with less
than a high school diploma. Median household income for
each ZIP code was based on self-reported income. Marital
status was defined as women aged 25 years and older in
each ZIP code who had never been married. Employment
status was defined as percentage of women aged 16 years
and older in each ZIP code who worked in 1989. Full-time
employment variable was defined as percentage of women
25 years and older in each ZIP code who worked at least 40
hours per week. Commuting time was divided into five cat-
egories of percentage of female workers in each ZIP code:
worked at home, commuted 1 to 14 minutes, commuted 15
to 29 minutes, commuted 30 to 44 minutes, and commuted
45 minutes or more. Age was defined as age at diagnosis.
These potential covariates were initially screened using
forward stepwise logistic regression models, which includ-
ed ZIP code as an exchangeable (nonspatially structured)
random effect. Covariates included in the best model
selected using Schwarz’s Bayesian Information Criterion
(BIC) (26) were used in the second covariate-adjusted
model. The covariate effects and the intercept were given
posterior priors.
Posterior estimates of the age-adjusted percentage of
BCIS for each ZIP code in each time period were obtained
from the CAR model. Posterior medians were used as
point estimates of the parameters, and 95% posterior
credible intervals were obtained. Analyses were per-
formed using WinBUGS software (27). Covariate screen-
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Figure 1. Map of Dane County, Wisconsin, showing capital city of Madison,
major lakes, active mammogram facilities, and percentage of area classified
as urban by ZIP code, using 1996 ZIP code boundaries and 1990 census
data. Inset map shows location of Dane County within the state.
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ing was performed using SAS software, version 8 (SAS
Institute Inc, Cary, NC). ZIP-code–specific estimates were
mapped using ESRI 3.2 ArcView software
(Environmental Systems Research Institute, Redwood,
Calif) and 1996 ZIP code boundary files to display the
data.
As an empirical check on our mapping, we fitted a
regression model to the BCIS rates by ZIP code. The
dependent variable was BCIS rates (using the posterior
estimates of age-adjusted percentage of BCIS), and the
independent variable in the model was linear distance
from the University of Wisconsin Comprehensive Cancer
Center (UWCCC), located in Madison, to the centroid of
each ZIP code.
Results
A total of 4769 breast cancer cases were reported in
Dane County from 1981 through 2000: 825 from 1981
through 1985, 1119 from 1986 through 1990, 1239 from
1991 through 1995, and 1586 from 1996 through 2000.
Percentage of cases in situ varied by age group from a high
of 18% among women aged 45 to 49 years to a low of 0%
among women aged 20 to 24 years. From the mid 1980s,
the age group most frequently diagnosed with BCIS was
women aged 45 to 49. In contrast, women aged 20 to 34
and older than 84 were the least often (<2%) diagnosed
with BCIS (data not shown). Based on the 1990 U.S. cen-
sus, the total female population (aged 18 years and older)
in Dane County was 145,974; 60% of the female population
had more than a high school degree, and 15% of the female
population aged 25 and older had never married.
In Dane County, the percentage of BCIS increased from
1.3% in 1981 to 11.9% in 2000. For the state, the percent-
age of BCIS increased from 1.5% in 1981 to 12.8% in 2000.
From 1981 to 1993, Dane County had a higher percentage
of BCIS diagnosis than the state as a whole. By the mid-
1990s, the percentage of BCIS among breast cancer cases
in Dane County was similar to the percentage in the state
(Figure 2). Similar results are seen when mapping the
observed data (maps not shown).
Figure 3 shows model-based estimates of the age-adjust-
ed percentage of BCIS diagnosis by ZIP code in Dane
County during four 5-year periods. These maps demon-
strate the increase in the percentage of cases diagnosed as
BCIS noted in Figure 2. These maps also show that the
increase in the percentage of BCIS was not uniform across
Dane County. From 1981 through 1985, the entire county
had uniformly low rates of BCIS (2%–3%). From 1986
through 1990, urban ZIP codes had markedly higher rates
of BCIS (approximately 12%) compared with rural ZIP
codes (approximately 5%). From 1991 through 1995, use of
mammography screening had begun to increase in the
rural ZIP codes (with a 7% rate of BCIS), although the
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Figure 2. Smoothed trends in percentage of breast cancer cases diagnosed
in situ (excluding lobular carcinoma in situ), Dane County, Wisconsin, and
Wisconsin, 1981–2000. Data point for Dane County, 1980, was estimated
from Andersen et al (28).  
Figure 3. Model-based estimates of age-adjusted percentage of breast can-
cer cases diagnosed in situ during four 5-year periods, by ZIP code, Dane
County, Wisconsin, 1981–2000. BCIS indicates breast cancer in situ.
rates of BCIS remained higher in urban ZIP codes (12%).
From 1996 through 2000, mammography screening was
fairly universal across the county, with BCIS rates of 13%
to 14%. Similar patterns were observed from models that
adjusted for additional covariates of marital status and
education (data not shown).
From 1981 through 1985, there was no significant rela-
tionship between distance from UWCCC and the rate of
BCIS (P = .27). From 1986 through 1990 and from 1991
through 1995, there was strong evidence of an inverse rela-
tionship between distance from UWCCC and the rate of
BCIS (i.e., the closer to UWCCC, the higher the BCIS rate
[P < .001] for both periods). From 1996 through 2000, there
was a nonsignificant inverse relationship between distance
from UWCCC and the rate of BCIS (P = .07).
Discussion
The frequency of BCIS diagnosis increased substan-
tially in Wisconsin and in Dane County from 1981
through 2000. This increase in percentage of BCIS
among diagnosed breast cancer cases is consistent with
increases in self-reported mammography use,
Wisconsin Medicare claims for mammography, and the
number of medical imaging centers in Wisconsin (21).
However, progress in mammography screening was not
uniform across Dane County, and this lack of uniformi-
ty represents a classic case of diffusion of innovation.
Early adopters of mammography use lived in and near
the city of Madison. We can speculate that Madison
embodies one characteristic that accelerates the diffu-
sion process: namely, a more highly educated popula-
tion living in a university community with a strong
medical presence. One predictor of mammography use
is education: women who are more educated are more
likely to ask their physician for a referral or to 
self-refer (29), and the strongest predictor of mammog-
raphy use is physician referral (30). Furthermore,
physicians are more likely to have chosen to live in the
Madison area instead of a more rural location because
they value the opportunity for regular contact with the
medical school and the medical community (31).
Consequently, a greater number of interpersonal net-
works and more information exchange among physi-
cians about adoption of this innovation might have
occurred earlier in the Madison medical community
than in the more rural areas of the county (32).
Although median household income by ZIP code was not
a predictor of mammography use in our study, the amount
of disposable income by individuals, which is not captured
by this variable, might also have been an important factor
for early adopters (33,34). In a national study of mammog-
raphy use, income was a significant predictor of repeat
screening in 1987 but not in 1990 (35). In the mid-1980s,
few insurance plans covered mammography screening.
Therefore, women of higher socioeconomic status (SES)
would have been more likely to be able to pay the cost of
the mammogram. Efforts to reduce costs, such as a 1987
statewide promotional campaign sponsored by the
American Cancer Society, still required a $50 copay from
women who were able to self-refer for a mammogram (36).
As the use of this technology diffused outward, increas-
ing numbers of women living in suburban and rural areas
surrounding Madison elected to get a mammogram. From
1996 through 2000, the geographic disparity in mammog-
raphy use was muted, although the eastern corridor of
Dane County still had slightly lower rates of BCIS than
other parts of the county. The reasons for persistent dis-
parity in this region of Dane County are unclear: it is
unlikely to be because of proximity to mammography
screening facilities, nor are the ZIP-code–level SES meas-
ures such as percentage unemployed, household income,
percentage below poverty level, or education level statisti-
cally different from the western corridor of Dane County.
Differences in the trends of early detection of breast can-
cer within Dane County suggest that progress in mam-
mography screening has not been uniform across the
county. From 1996 through 2000, while more than 14% of
age-adjusted breast cancer cases were diagnosed as BCIS
in Madison, fewer than 6% of age-adjusted breast cancer
cases were diagnosed as BCIS in a few outlying and more
rural areas of Dane County, reflecting lower mammogra-
phy use by residents in this area. The results of an earli-
er analysis of these data were shared with local health
department staff in rural Dane County who were working
to increase early detection efforts through outreach edu-
cation and referrals to providers. As suggested by
Andersen et al, strategies to improve mammography use
include improving access to primary care physicians,
increasing the number of mammography facilities located
in rural areas, and increasing outreach efforts by a net-
work of public health professionals promoting screening in
their community (28). In addition, pointing out the varia-
tions in care may lead to improvements, since the first step
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toward change is identifying a problem. With identification
of particular areas of need, resources can be garnered
toward alleviating the disparity.
Persistent disparities in mammography use after
adjusting for community level of educational attainment
and marital status were found. Other studies have found
that patients with cancer living in census tracts with
lower median levels of education attainment are diag-
nosed in later disease stages than are patients in tracts
with higher median levels of education (29). Studies have
also shown that one predictor for getting a mammogram
is being married (37).
This study demonstrates the use of percentage of BCIS
as a tool for comparing population-based mammography
screening rates in different geographic areas. Using cancer
incidence data to monitor population-based rates of breast
cancer screening is possible throughout the nation,
because data from population-based cancer registries are
now widely available, often by ZIP code or census tract.
This method permits comparison of mammography screen-
ing rates among geographic areas smaller than areas used
in many previous studies of geographic variation in the
early detection of breast cancer (2).
The method described in this article can be used to com-
plement other ways to assess the quality of health care in
communities, such as the Health Plan Employer Data and
Information Set (HEDIS), created by the National
Committee for Quality Assurance. HEDIS addresses over-
all rates in managed care but does not include the under-
insured or fee-for-service populations particularly at risk
for inadequate screening (34). Cancer registry data are
population based; therefore, using cancer registry data is
not only effective but also economical and efficient for out-
reach specialists and health providers.
A potential weakness in this method is the representa-
tiveness of the statewide tumor registry. However, the
WCRS has been evaluated by the North American
Association of Central Cancer Registries and was given its
gold standard for quality, completeness, and timeliness in
1995 and 1996, the first 2 years this standard was recog-
nized (38). Completeness estimates are a general measure
of accuracy. The WCRS participated in national audits
that measured completeness in 1987, 1992, and 1996 as
well as one formal study in 1982. Overall, the quality of
the data improved slightly after 1994 when clinics and
neighboring state data-sharing agreements were imple-
mented (oral communication, Laura Stephenson, WCRS,
July 2005). In addition, the tumor registry has used stan-
dard methods for classifying tumor stage (e.g., in situ)
throughout the entire period of the study. Incidence data
from data sources of lesser quality or completeness than
the WCRS would need to be carefully evaluated for use in
this type of analysis.
Another limitation of this type of analysis is our use of
BCIS as a proxy for mammography screening practices.
Undoubtedly, some diagnoses of BCIS result from diag-
nostic mammograms, but reported use of screening mam-
mograms by individuals and medical facilities correlates
strongly with percentage of BCIS over time, particularly
ductal carcinoma in situ (18-20). Furthermore, we chose to
exclude lobular carcinoma in situ from our BCIS category
because this condition is often opportunistic (13-15).
A third limitation, which would be found in any type of
geographic analysis, rests on the accuracy of the assign-
ment of participants to the proper location. For area analy-
sis (e.g., ZIP code, county), this legitimate concern is ame-
liorated by using tools to check ZIP codes and county
assignments for correctness. For this study, women diag-
nosed with breast cancer provided their addresses, includ-
ing county of residence, to their medical facilities. These
addresses were forwarded to the WCRS, where quality-
control checks were implemented to validate ZIP code and
county assignments. For example, lists of ZIP codes and
their county codes were cross-referenced to the ZIP codes
and county codes of the addresses provided by the women
diagnosed with breast cancer. Inaccuracies were corrected
by the WCRS (oral communication, Laura Stephenson,
WCRS, January 2005).
Although there has been significant improvement in
breast cancer screening across the state and county, this
study demonstrates that the improvement has not been
uniform. The maps clearly indicate for program direc-
tors and policy makers the areas where further outreach
and research should be conducted. More specifically,
this type of analysis can be used to identify specific
areas (such as ZIP codes) within a community (such as
a county) with varying rates of early-stage breast can-
cer. Using this method, public health professionals can
provide population-level data to all health care providers
to target interventions to improve the early detection of
breast cancer in other counties in Wisconsin and other
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states. Finally, this type of analysis is useful for compre-
hensive cancer control efforts and can be conducted for
other cancers with effective screening methods, such as
colorectal cancer.
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